Lorlatinib in ALK- and ROS1-positive NSCLC: the future has a start

由 Facchinetti, Francesco, Friboulet, Luc
發表在 Transl Lung Cancer Res (2018)

No room for statins in the quest for survival benefits in small cell lung cancer

由 Facchinetti, Francesco, Tiseo, Marcello
發表在 Transl Lung Cancer Res (2018)

Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date

由 Facchinetti, Francesco, Friboulet, Luc
發表在 Lung Cancer (Auckl) (2019)

Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?

由 Leonetti, Alessandro, Facchinetti, Francesco, Tiseo, Marcello
發表在 Ann Transl Med (2018)

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

由 Facchinetti, Francesco, Di Maio, Massimo, Tiseo, Marcello
發表在 Cancers (Basel) (2020)

Cystic brain metastases and RET fusion in lung cancer

由 Remon, Jordi, Facchinetti, Francesco, Besse, Benjamin, Tiseo, Marcello
發表在 Transl Lung Cancer Res (2020)

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis

由 Facchinetti, Francesco, Di Maio, Massimo, Perrone, Fabiana, Tiseo, Marcello
發表在 Transl Lung Cancer Res (2021)

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

由 Facchinetti, Francesco, Bordi, Paola, Leonetti, Alessandro, Buti, Sebastiano, Tiseo, Marcello
發表在 Drug Des Devel Ther (2018)

New pathways in immune stimulation: targeting OX40

由 Alves Costa Silva, Carolina, Facchinetti, Francesco, Routy, Bertrand, Derosa, Lisa
發表在 ESMO Open (2020)

COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

由 Leonetti, Alessandro, Facchinetti, Francesco, Zielli, Teresa, Brianti, Elena, Tiseo, Marcello
發表在 Eur J Cancer (2020)

Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with Gefitinib

由 Gozzi, Fabrizio, Tiseo, Marcello, Facchinetti, Francesco, Gandolfi, Stefano, Rubino, Pierangela
發表在 Case Rep Ophthalmol (2021)

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

由 Guaitoli, Giorgia, Tiseo, Marcello, Di Maio, Massimo, Friboulet, Luc, Facchinetti, Francesco
發表在 Transl Lung Cancer Res (2021)

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

由 Facchinetti, Francesco, Tiseo, Marcello, Di Maio, Massimo, Graziano, Paolo, Bria, Emilio, Rossi, Giulio, Novello, Silvia
發表在 Transl Lung Cancer Res (2016)

Facts and new hopes on selective FGFR inhibitors in solid tumors

由 Facchinetti, Francesco, Hollebecque, Antoine, Bahleda, Rastislav, Loriot, Yohann, Olaussen, Ken A, Massard, Christophe, Friboulet, Luc
發表在 Clin Cancer Res (2019)

Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib

由 Facchinetti, Francesco, Levy, Antonin, Ammari, Samy, Naltet, Charles, Lavaud, Pernelle, Aldea, Mihaela, Vasseur, Damien, Planchard, David, Besse, Benjamin
發表在 Cancer Manag Res (2021)

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives

由 Rossi, Giulio, Jocollé, Genny, Conti, Antonia, Tiseo, Marcello, Zito Marino, Federica, Donati, Giovanni, Franco, Renato, Bono, Francesca, Barbisan, Francesca, Facchinetti, Francesco
發表在 Lung Cancer (Auckl) (2017)

Systemic thromboembolism from a misdiagnosed non-bacterial thrombotic endocarditis in a patient with lung cancer: A case report

由 Perrone, Fabiana, Biagi, Andrea, Facchinetti, Francesco, Bozzetti, Francesca, Ramelli, Andrea, Vezzani, Antonella, Manca, Tullio, Gnetti, Letizia, Majori, Maria, Alfieri, Veronica, Tiseo, Marcello
發表在 Oncol Lett (2020)

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors

由 Dall’Olio, Filippo G., Abbati, Francesca, Facchinetti, Francesco, Massucci, Maria, Melotti, Barbara, Squadrilli, Anna, Buti, Sebastiano, Formica, Francesca, Tiseo, Marcello, Ardizzoni, Andrea
發表在 Ther Adv Med Oncol (2020)

Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID‐19 patient

由 Ugolotti, Maria C., Pedrazzini, Massimo, Silini, Enrico M., Missale, Gabriele, Silva, Mario, Franzini, Christian, Palmieri, Gerardo, Costi, Renato, Montali, Filippo, Gnappi, Elisa, Terroni, Lorenza, Colizzi, Elena, Meschi, Michele, Facchinetti, Francesco
發表在 J Med Virol (2021)

Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies

由 Facchinetti, Francesco, Loriot, Yohann, Brayé, Floriane, Vasseur, Damien, Bahleda, Rastislav, Bigot, Ludovic, Barbé, Rémy, Nobre, Catline, Combarel, David, Michiels, Stefan, Italiano, Antoine, Smolenschi, Cristina, Tselikas, Lambros, Scoazec, Jean-Yves, Ponce-Aix, Santiago, Besse, Benjamin, André, Fabrice, Olaussen, Ken A., Hollebecque, Antoine, Friboulet, Luc
發表在 Clin Cancer Res (2024)